Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma

被引:12
|
作者
Pienkowska-Grela, B [1 ]
Witkowska, A [1 ]
Grygalewicz, B [1 ]
Rymkiewicz, G [1 ]
Rygier, J [1 ]
Woroniecka, R [1 ]
Walewski, J [1 ]
机构
[1] Mem M Sklodowska Curie Canc Ctr & Inst, Cytogenet Lab, PL-02781 Warsaw, Poland
关键词
D O I
10.1016/j.cancergencyto.2004.04.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Translocations involving chromosome 8 are the most common aberrations in B-cell non-Hodgkin lymphoma (B-NHL). The presence of the typical t(8; 14)(q24;q32) or its variants has been confirmed in all cases of Burkitt lymphoma (BL), in some cases of Burkitt-like lymphoma (BLL), and in diffuse large B-cell lymphoma (DLBCL). The alterations lead to deregulated expression of c-myc protein by a chromosomal translocation joining C-MYC gene with sequences from immunoglobulin (Ig) enhancers. The C-MYC gene rearrangement plays an essential role in leukemogenesis of BL and probably plays a part in other aggressive NHLs. The present study was undertaken to compare the cytogenetic features in cases of BL, BLL, and DLBCL. We detected chromosomal aberrations by G-banding and fluorescence in situ hybridization (FISH) painting in 10 cases of aggressive B-NHL and used FISH to visualize the C-MYC gene rearrangement. Chromosome 8 was most frequently involved in structural aberrations (8/10 cases), and 4 cases showed the typical t(8;14)(q24;q32). Only two of 5 patients suspected of having BL fulfilled all the criteria for this diagnosis; in the others, chromosome 8 was aberrant, but the absence of C-MYC rearrangement or the results of flow cytometry excluded the diagnosis of BL. All BLL cases showed C-MYC overexpression, but only one had a rearrangement of the C-MYC gene; the remaining cases showed other aberrations of chromosome 8. This study indicates that the mechanisms of C-MYC activation involved in BLL can be different from that for the BL. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 121
页数:8
相关论文
共 50 条
  • [1] Immunotherapeutic concepts for aggressive B-cell non-Hodgkin's Lymphoma
    Krackhardt, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 10 - 11
  • [2] Cystatin C in sera of patients with aggressive non-Hodgkin B-cell lymphoma
    Softic, Adaleta
    Begic, Leila
    Halilbasic, Alma
    Kos, Janko
    MEDICINSKI GLASNIK, 2011, 8 (01) : 97 - 100
  • [3] Evaluation of cachexia and outcomes in patients with aggressive B-cell non-Hodgkin lymphoma
    Demetriou, Nicholas
    Burkart, Madelyn
    Sunderraj, Ashwin
    Ma, Shuo
    Winter, Jane N.
    Gordon, Leo I.
    Karmali, Reem
    Roy, Ishan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Treatment of relapsed/refractory paediatric aggressive B-cell non-Hodgkin lymphoma
    Moleti, Maria L.
    Testi, Anna M.
    Foa, Robin
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) : 826 - 843
  • [5] Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell
    Liang, R
    Todd, D
    Ho, FCS
    HEMATOLOGICAL ONCOLOGY, 1996, 14 (01) : 1 - 6
  • [6] Radioimmunotherapy for B-cell non-Hodgkin lymphoma
    Witzig, Thomas E.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (04) : 655 - 668
  • [7] PH-CHROMOSOME IN A PATIENT WITH NONLEUKEMIC NON-HODGKIN B-CELL LYMPHOMA
    FUJII, H
    YASHIGE, H
    MISAWA, S
    TANAKA, S
    URATA, Y
    MATUYAMA, F
    AMERICAN JOURNAL OF HEMATOLOGY, 1990, 35 (03) : 213 - 215
  • [8] Synthetic lethal approaches to aurora inhibition in aggressive B-cell non-Hodgkin lymphoma
    Mahadevan, Daruka
    Morales, Carla
    Cooke, Laurence
    Pandey, Manjari
    Spier, Catherine
    Qi, Wenqing
    CANCER RESEARCH, 2015, 75
  • [9] Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma
    Toelle, I
    Lanvers-Kaminsky, C.
    Bethke, M.
    Randau, G.
    Rolfi, Ng M.
    Tann, A.
    te Vrugt, M.
    Mellgren, K.
    Mueller, S.
    Burkhardt, B.
    KLINISCHE PADIATRIE, 2023, 235 (03): : 203 - 203
  • [10] Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
    Armand, Philippe
    Oki, Yasuhiro
    Neuberg, Donna S.
    Faham, Malek
    Cummings, Craig
    Klinger, Mark
    Weng, Li
    Bhattar, Sangeetha
    LaCasce, Ann S.
    Jacobsen, Eric D.
    Davids, Matthew S.
    Jacobson, Caron
    Fisher, David C.
    Brown, Jennifer R.
    Fowler, Nathan H.
    Rodriguez, M. Alma
    Wallace, Michael J.
    Neelapu, Sattva S.
    Rodig, Scott
    Younes, Anas
    Freedman, Arnold S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (01) : 123 - 126